Provided by Tiger Trade Technology Pte. Ltd.

Enveric Biosciences

1.41
-0.0200-1.40%
Post-market: 1.410.00000.00%16:10 EDT
Volume:58.01K
Turnover:82.53K
Market Cap:6.31M
PE:-0.19
High:1.47
Open:1.44
Low:1.37
Close:1.43
52wk High:17.64
52wk Low:1.25
Shares:4.48M
Float Shares:4.34M
Volume Ratio:0.25
T/O Rate:1.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.4858
EPS(LYR):-36.2437
ROE:-170.04%
ROA:-87.34%
PB:0.78
PE(LYR):-0.04

Loading ...

Enveric Biosciences files to sell 6.82M shares of common stock

TIPRANKS
·
Apr 24

Enveric Biosciences Inc - Files Prospectus for Resale of up to 6.82 Mln Shares - SEC Filing

THOMSON REUTERS
·
Apr 24

Enveric Biosciences CEO joins Needham Virtual Psychedelics Forum panel discussion

Reuters
·
Apr 21

Enveric Biosciences Stock Soars After Trump's Psychedelics Executive Order

Benzinga
·
Apr 21

Definium Therapeutics Adds 15.3%, Compass Pathways Rises 40%, GH Research Gains 16.4%

THOMSON REUTERS
·
Apr 20

Enveric Biosciences up 150%, U.S.‑Listed Shares of Cybin Rise 2.7%

THOMSON REUTERS
·
Apr 20

Psychedelic Drug Developers Rise Premarket After Trump Orders FDA to Expedite Reviews

THOMSON REUTERS
·
Apr 20

Definium Therapeutics up 14.5%, Compass Pathways up 21.5%, GH Research up 18.9%, Enveric Biosciences up 6.6%, U.S.‑Listed Shares of Cybin up 15.5%

THOMSON REUTERS
·
Apr 20

BUZZ-Psychedelic drug developers rise after Trump signals regulatory support

Reuters
·
Apr 20

Top Midday Decliners

MT Newswires Live
·
Apr 18

Enveric Biosciences prices $13.9M at-the-market offering

TIPRANKS
·
Apr 17

Enveric Biosciences prices $5 million Nasdaq at-the-market private placement at $2.25/share

Reuters
·
Apr 17

Enveric Biosciences Announces up to $13.9 Million Private Placement Priced at-the-Market Under Nasdaq Rules

THOMSON REUTERS
·
Apr 17

Trump Administration Eyes Ibogaine Research For PTSD Treatment, Stock Jumps

Benzinga_recent_news
·
Apr 17

BUZZ-Psychedelic drug developers rise after CBS report Trump backs more research

Reuters
·
Apr 17

Enveric Biosciences wins new US patent covering EVM301 drug candidates including EB-003

Reuters
·
Apr 01

BRIEF-Enveric Biosciences Inc - Receives U.S. Patent For Evm301 Series Of Drug Candidates On March 17

Reuters
·
Mar 31

Enveric Biosciences Inc - Receives U.S. Patent for Evm301 Series of Drug Candidates on March 17

THOMSON REUTERS
·
Mar 31

Enveric Biosciences Q4 EPS $(0.50) Up From $(57.96) YoY

Benzinga Earnings
·
Mar 28

Press Release: Enveric Biosciences Reports Financial Results and Provides Corporate Update for Fourth Quarter and Fiscal Year Ended 2025

Dow Jones
·
Mar 28